Neonc Technologies Holdings, .
Clinical-stage life sciences company developing a novel intranasal drug delivery system for brain cancers and CNS diseases.
About
Pricing
View pricing page ↗
Technology stack
detected 2026-06-28“The company is a clinical-stage biopharmaceutical business, developing treatments for brain cancers. It is offering 2.95M shares, expecting proceeds. The money will be used for general corporate purposes.”
View on Reddit“The company, formed in 2008, is a clinical-stage biopharmaceutical business developing treatments for brain cancers. It has two lead products: NEO100, delivered intranasally, and NEO212.”
View on Reddit“NeOnc Technologies found that ultrasound enhances NEO100's effectiveness in treating brain tumors, according to preclinical research at USC. AI-driven study showed increased tumor-killing activity using NEO100 with focused ultrasound.”
View on Reddit“The President, a Director, and a 10% Owner, Amir F Heshmatpour, executed multiple open-market purchases totaling approximately $185,000, reinforcing his already substantial position in the company. Market Impact : This series of buys is a b…”
View on Reddit“NeOnc Technologies reported Q3 2025 results, highlighted operational updates including NEO100 Phase 2a data, FDA clearance for NEO212, and a $50M strategic partnership, with key milestones anticipated.”
View on RedditSome comments are pulled from public discussions around the web (look for the source icon). Quotes are excerpts; click through to read the full thread.
What does Neonc Technologies Holdings, . do?
NeOnc Technologies Holdings, Inc. is pioneering a new era in brain health by revolutionizing the treatment of Central Nervous System (CNS) diseases. The company has developed a proprietary, patented platform technology designed to transport therapeutics directly to the brain, overcoming the limitations of the Blood-Brain Barrier (BBB). This innovative approach aims to deliver more effective treatments for CNS diseases, including brain cancers, by leveraging their breakthrough discovery of Perill…
What industry does Neonc Technologies Holdings, . operate in?
Neonc Technologies Holdings, . operates in MedTech, HealthTech, Drug Discovery, Clinical Trials, Biotech, Neurotech.
How many employees does Neonc Technologies Holdings, . have?
Neonc Technologies Holdings, . has approximately 8 people on record.